Kasabach‐Merritt Syndrome
- 1 June 1991
- journal article
- case report
- Published by Wiley in Pediatric Dermatology
- Vol. 8 (2) , 133-136
- https://doi.org/10.1111/j.1525-1470.1991.tb00303.x
Abstract
The Kasabach-Merritt syndrome includes the triad of vascular tumors, thrombocytopenia, and a hemorrhagic diathesis. The vascular tumors are usually benign but the associated coagulopathy may be life threatening. We describe a patient whose clinical course illustrates the potential difficulties in management.Keywords
This publication has 27 references indexed in Scilit:
- Combination treatment for massive cavernous hemangioma of the face: YAG laser photocoagulation plus direct steroid injection followed by YAG laser resection with sapphire scalpel tips, aided by superselective embolizationLasers in Surgery and Medicine, 1990
- Kasabach-Merritt syndromeJournal of Pediatric Surgery, 1988
- Treatment of Severe Coagulopathy in the Kasabach-Merritt Syndrome with Aminocaproic Acid and CryoprecipitateNew England Journal of Medicine, 1985
- Kasabach-Merritt syndrome in infantsJournal of the American Academy of Dermatology, 1983
- Giant hemangioma with consumption coagulopathyThe Journal of Pediatrics, 1975
- Hemangioma-thrombocytopenia syndrome; a disseminated intravascular coagulopathyArchives of Dermatology, 1975
- Chronic intravascular coagulation in Kasabach-Merritt syndrome. Preferential accumulation of fibrinogen 131 I in a giant hemangiomaArchives of internal medicine (1960), 1972
- Hemangioma and thrombocytopeniaJournal of Pediatric Surgery, 1970
- HEPARIN TREATMENT OF BLEEDINGThe Lancet, 1963